Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGallbladder problems are a recognised side effect of tirzepatide, and knowing how to reduce that risk makes a real practical difference. Rapid weight loss and changes in how the gut moves bile both play a part — but diet timing, fat intake and hydration give you levers you can actually pull. These are prescription-only medicines; a prescriber assesses suitability and discusses your personal risk picture before treatment starts. This page covers what the evidence says and what you can do day to day to keep your gallbladder as settled as possible while on Mounjaro.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Understanding the mechanism helps make the advice feel less arbitrary. Tirzepatide slows how quickly the stomach empties and alters gut-hormone signalling, both of which change the pattern and volume of bile the gallbladder releases. When bile sits stagnant for longer than usual, cholesterol crystals can accumulate and eventually form stones. Rapid weight loss compounds this: as fat cells release cholesterol into circulation, bile becomes more saturated and harder to keep liquid. The biological reasons behind this link are worth understanding if you want to go deeper, but the short version is that gallbladder risk on GLP-1 and dual-agonist medicines is real, documented and manageable rather than inevitable.
The NHS medicines information for tirzepatide lists cholelithiasis (gallstones) and cholecystitis (inflammation of the gallbladder) as known side effects. If you have a personal or family history of gallstones, tell your prescriber before starting, that conversation should happen at consultation, not after your first pen arrives.
For a broader map of how tirzepatide affects different body systems, the full Mounjaro side effects overview covers the GI, metabolic and injection-site picture alongside gallbladder risk.
The single most useful habit is eating regular, small meals rather than skipping them. A prolonged fast (even an accidental one, like forgetting lunch because your appetite has dropped so sharply) means bile pools in the gallbladder without a stimulus to contract. Eating a small amount of healthy fat at each meal (think a drizzle of olive oil, a few nuts, half an avocado) gives the gallbladder a reason to contract and release bile before it stagnates. Very low-fat diets, paradoxically, increase gallstone risk on GLP-1-type medicines by removing that stimulus altogether.
Hydration matters too. Concentrated bile is more prone to forming crystals, so keeping fluid intake steady across the day is worth the habit. Aim for consistent sips rather than large amounts at once, particularly given that nausea is common in the early weeks, small volumes are easier to keep down.
Dose escalation is slower for a reason. The titration schedule built into Mounjaro treatment is partly about tolerability, but slower weight loss (which typically accompanies a measured dose increase) gives the gallbladder more time to adapt than a sudden large caloric deficit would. Resist the urge to fast aggressively on top of treatment. Our prescribers cover this kind of lifestyle interaction during the consultation process, it is not a footnote.
The relationship between tirzepatide and gallbladder function is explored further on the Mounjaro and gallbladder page if you want more clinical detail.
This is the part of the page that matters most. Gallbladder problems can range from a dull ache that settles overnight to acute cholecystitis that needs hospital treatment, so reading symptoms correctly is important.
Seek urgent medical attention if you develop severe pain in the upper right side of your abdomen that lasts more than a few hours, particularly if it radiates to your right shoulder or between your shoulder blades, is accompanied by fever, jaundice (yellowing of skin or eyes) or dark urine, or comes with vomiting you cannot control. These are potential signs of gallbladder inflammation or a blocked bile duct, situations that need assessment the same day, not the next GP appointment slot.
Milder, brief discomfort after a fatty meal is worth noting and mentioning to your prescriber, but is not itself an emergency. Keep a note of when it happens and what you ate, that pattern is useful clinical information. The guide to gallbladder pain on Mounjaro explains how to distinguish ache from alarm.
If symptoms are acute, call 111 or go to A&E. Do not take an extra dose of tirzepatide while gallbladder symptoms are active and unassessed. Stop the pen and contact a clinician first. You can also report suspected side effects directly to the MHRA via the Yellow Card scheme, online, by phone, or through the app.
The NHS tirzepatide medicines page lists the full side-effect profile and the symptoms that need prompt attention. It is worth bookmarking alongside your Patient Information Leaflet.
No. Most people on tirzepatide do not develop clinically significant gallbladder disease, but the risk is higher than in the general population not on rapid-weight-loss treatment, which is why it sits on the prescriber's radar throughout. The SURMOUNT clinical trial programme reported gallbladder-related events in a minority of participants, and existing guidance reflects that risk at a population level. Individual risk depends on baseline factors: previous gallstones, a high starting weight, how quickly weight is lost and how much dietary fat is consumed.
The tirzepatide gallbladder risk data page covers the trial figures specifically. For the broader question of how tirzepatide's effects on the gallbladder compare with what other GLP-1 medicines do, the detailed look at Mounjaro's gallbladder effects is worth reading before you start or if you are weighing up options.
If you are already on treatment and want to flag a concern, reach our team through the support line. And if you are still at the considering-starting stage, our prescribers discuss your individual risk factors, including gallbladder history, as part of every consultation, check whether Mounjaro is clinically appropriate for you by starting your free eligibility assessment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.